Published in Clin J Am Soc Nephrol on November 11, 2010
Cross-sectional and longitudinal association between hemoglobin concentration and hypertension: A population-based cohort study. Medicine (Baltimore) (2016) 0.75
Association between alcohol-induced erythrocyte membrane alterations and hemolysis in chronic alcoholics. J Clin Biochem Nutr (2016) 0.75
High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease. Mediators Inflamm (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature (1996) 6.63
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA (2005) 6.49
Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med (2003) 4.98
Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science (1997) 4.29
Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation (2001) 3.14
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest (2005) 2.75
Haemoglobin targets: we were wrong, time to move on. Lancet (2007) 2.26
The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A (1999) 1.99
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation (1998) 1.86
Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta (1998) 1.81
Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol (2006) 1.74
Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci U S A (2001) 1.45
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation (1995) 1.38
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol (2005) 1.33
Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol (2009) 1.27
Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation (2004) 1.11
Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis (2008) 1.09
Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep (2003) 1.05
Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension (1998) 1.02
Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost (2000) 0.98
Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension (1992) 0.97
Endothelial dysfunction in patients with polycythaemia vera. Br J Haematol (2001) 0.95
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J (2005) 0.94
Haemoglobin and flow-mediated vasodilation. Clin Sci (Lond) (2006) 0.82
Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension. Eur Heart J (2005) 0.81
Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease? Curr Opin Nephrol Hypertens (2006) 0.81
Gly460Trp alpha-adducin gene polymorphism and endothelial function in untreated hypertensive patients. J Hypertens (2007) 0.79
S-nitrosohemoglobin is distinguished from other nitrosovasodilators by unique oxygen-dependent responses that support an allosteric mechanism of action. Blood (2003) 0.78
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol (2013) 2.05
Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol (2006) 1.74
Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care (2003) 1.72
Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol (2003) 1.67
Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care (2007) 1.65
Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes (2006) 1.49
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. Am J Hypertens (2007) 1.43
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity (Silver Spring) (2008) 1.42
Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care (2005) 1.38
The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 1.36
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol (2005) 1.33
The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab (2008) 1.32
Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care (2012) 1.16
Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation (2010) 1.14
Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr (2006) 1.12
Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension. Diabetes (2007) 1.10
One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol (2010) 1.08
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes (2004) 1.05
Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Int J Cardiol (2009) 1.02
Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab (2011) 1.01
Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care (2012) 0.99
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab (2006) 0.99
The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail (2006) 0.98
One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care (2011) 0.97
Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes (2006) 0.96
Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. Endocrinology (2009) 0.95
Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol (2007) 0.95
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. Acta Diabetol (2013) 0.94
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. Diabetes Care (2004) 0.93
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2013) 0.93
One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care (2011) 0.93
Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation (2002) 0.92
A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep (2013) 0.90
Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS One (2012) 0.90
Serum uric acid and 1-h postload glucose in essential hypertension. Diabetes Care (2011) 0.90
Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension. J Am Soc Nephrol (2006) 0.90
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol (2009) 0.88
Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients. Int J Cardiol (2012) 0.88
Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev (2007) 0.87
Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. Am J Cardiol (2011) 0.87
Glutamine to arginine substitution at amino acid 84 of mammalian tribbles homolog TRIB3 and CKD in whites with type 2 diabetes. Am J Kidney Dis (2007) 0.87
Large brachial and common carotid artery diameter in postmenopausal women with carotid atherosclerosis. Atherosclerosis (2007) 0.87
Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. Eur J Endocrinol (2010) 0.86
Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women. Eur J Cardiovasc Prev Rehabil (2009) 0.86
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) (2011) 0.86
Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study. J Clin Hypertens (Greenwich) (2003) 0.85
Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects. Diabetes Care (2008) 0.85
Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis (2007) 0.85
The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. Cardiovasc Res (2010) 0.84
Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold. Diabetes Metab Res Rev (2007) 0.83
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. Atherosclerosis (2011) 0.83
Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients. J Hypertens (2009) 0.83
Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene. J Clin Endocrinol Metab (2004) 0.82
Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension. J Nephrol (2007) 0.82
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol (2014) 0.81
Identifying older diabetic patients at risk of poor glycemic control. BMC Geriatr (2002) 0.81
Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension. Eur Heart J (2005) 0.81
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. PLoS One (2012) 0.81
Programmed electrical stimulation and Amiodarone therapy for the control of persistent junctional tachycardia. Cardiovasc Dis (1981) 0.81
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels. PLoS One (2013) 0.81
Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study. Pharmacogenomics (2014) 0.81
Association of insulin resistance indexes to carotid intima-media thickness. PLoS One (2013) 0.80
Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Diabetes Metab Res Rev (2009) 0.80
Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J Hypertens (2007) 0.80